Brought to you by 
CathWorks closes $30mm Series C
05 Feb 2019
Executive Summary
Cardiovascular device maker CathWorks Ltd. raised $30mm in its Series C financing round led by Deerfield Management. In late 2018, CathWorks received 510(k) clearance for its FFRangio system, which can potentially become standard of care in percutaneous coronary intervention. Funds from the financing will support US clinical and commercial activities for the system.
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CathWorks closes $30mm Series C
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice